Skip to main content

Stock Update (NYSE:GE): The NBA and GE Healthcare Announce First Round Research Winners to Address Prevention, Diagnosis and Treatment of Musculoskeletal Injuries

[Business Wire] – The National Basketball Association and GE Healthcare today announced the first round of winning research proposals submitted to their Sports Medicine and Orthopedics Collaboration. Read more on this. General Electric Company (GE) , valued at $279.20B, began trading this morning at $30.40. Today’s price range has been between $29.89 and $30.42 per share with its 52-week range being $19.37 to $32.05. Priced at 19.91x this year’s forecasted earnings, GE shares are relatively expensive compared to the industry’s 16.50x forward p/e ratio. And for income investors, the company pays shareholders $0.92 per share annually in dividends, yielding 2.99%. In a review of the consensus earnings estimate this quarter, 13 sell-side analysts are looking at $0.43 per share, which would be $0.12 better than the year-ago quarter and a $0.15 sequential increase. What we find to be interesting is that the full-year EPS estimate of $1.51 is a $0.20 better when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $30.69 Billion. If reported, that would be a 3.47% increase over the year-ago quarter. In terms of ratings, Bernstein downgraded GE from Outperform to Mkt Perform (Apr 4, 2016). Previously, UBS Initiated GE at to Buy. When considering if the stock is under or overvalued, the average price target is $33.17, which is 9.11% above where the stock opened this morning. See more in (NYSE:GE) Similar Articles: Stock Update: General Electric Company (NYSE:GE) – DILON Diagnostics and GE Healthcare will present GE Healthcare’s FDA 510k pending dual head MBI localization accessory for breast biopsy* at the SBI/ACR Breast Imaging Symposium in April 7-9 Stock Update (NYSE:GE): LeukoDx and GE Healthcare Enter Agreement to Explore Solutions for Cell Characterization in Cell Therapy Manufacturing Company Update: General Electric Company (NYSE:GE) – 81% of Consumers are Unsatisfied with their Healthcare Experience, According to a New Study by Prophet and GE Healthcare Camden Group
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.